Analysis: Ventria on ITC win barring rHSA products

Last month, October 2022, the US International Trade Commission ( ITC) affirmed an administrative law judge’s (ALJ’s) finding that products containing recombinant human serum albumins (rHSAs) made by a Chinese company infringe a patent belonging to Ventria Bioscience.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Abbott fends off Chinese rival’s patent challenge at UPC

18 August 2026 The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.

Careers

Former head of litigation at Nokia returns to Bird & Bird

18 August 2026 The new partner counts pharmaceuticals and life sciences among his specialisms and previously worked in-house at Sandoz.

Careers

Former USPTO acting director takes the helm at C4IP

17 August 2026 The IP advocacy group has turned to former USPTO acting director Coke Morgan Stewart as it enters what it calls a “new chapter”.